“十年内，中国生物科技企业将取得重大突破”

Core Viewpoint - Chinese biotechnology companies are expanding into global markets after achieving success domestically, with significant breakthroughs expected in the next decade due to strengthened manufacturing bases and supply chains, alongside growing global demand for biotechnology [1][2]. Industry Development - The domestic biomanufacturing industry has rapidly developed, producing a variety of daily products from cosmetics to pharmaceuticals, with the government recognizing biomanufacturing as a key future industry [1]. - The total scale of China's biomanufacturing industry is nearly 1 trillion yuan, with fermentation capacity accounting for over 70% of the global total [1]. - The 2025 China Biomanufacturing Technology Innovation Forum highlighted the importance of biomanufacturing in China's industrial landscape, while also acknowledging challenges such as the need for improved data quality and algorithm models [6]. Global Expansion - Companies like WuXi Biologics are actively pursuing international expansion, as evidenced by their strategic partnership with Qatar Free Zones Authority to establish a comprehensive contract research and manufacturing center in the Middle East [1]. - Overseas orders constitute about 50% of sales for some companies, indicating a strong demand for closer supply chains and production facilities in international markets [2]. Innovation and Intellectual Property - Companies must innovate to maintain competitive advantages as they expand globally, moving beyond traditional focuses on scale and cost efficiency [5]. - The number of patent applications from major biomanufacturing companies in China has surged, with 13,680 patents filed in the last five years, representing 52.2% of the historical total [5]. - The importance of patent protection and technological independence is emphasized, as companies face potential legal challenges and trade barriers in foreign markets [5]. Policy and Support - The Ministry of Industry and Information Technology plans to enhance policy support and top-level design for biomanufacturing, focusing on innovation and collaborative mechanisms to overcome key technological challenges [6].